Single dose bioequivalence study of epoetin zeta (Hospira) and Epogen in healthy subjects

Trial Profile

Single dose bioequivalence study of epoetin zeta (Hospira) and Epogen in healthy subjects

Completed
Phase of Trial: Phase I

Latest Information Update: 26 Jul 2016

At a glance

  • Drugs Epoetin zeta (Primary) ; Epoetin alfa
  • Indications Anaemia
  • Focus Pharmacodynamics; Pharmacokinetics
  • Sponsors Hospira
  • Most Recent Events

    • 31 Mar 2015 New trial record
    • 27 Mar 2015 Results published in Hospira media release.
    • 27 Mar 2015 Results presented at the National Kidney Foundation (NKF) spring meeting, according to a Hospira media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top